Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment

In English

Författare

  • Marcin Kruczyk
  • Henrik Zetterberg
  • Oskar Hansson
  • Sindre Rolstad
  • Lennart Minthon
  • Anders Wallin
  • Kaj Blennow
  • Jan Komorowski
  • Mats Gunnar Andersson

Summary, in English

The objective of the present study was to evaluate a Monte Carlo feature selection (MCFS) and rough set Rosetta pipeline for generating rule-based models as a tool for comprehensive risk estimates for future Alzheimer's disease (AD) in individual patients with mild cognitive impairment (MCI). Risk estimates were generated on the basis of age, gender, Mini-Mental State Examination scores, apolipoprotein E (APOE) genotype and the cerebrospinal fluid (CSF) biomarkers total tau (T-tau), phospho-tau(181) (P-tau) and the 42 amino acid form of amyloid beta (A beta 42) in two sets of longitudinally followed MCI patients (n = 217 in total). The predictive model was created in Rosetta, evaluated with the standard tenfold cross-validation approach and tested on an external set. Features were ranked and selected by the MCFS algorithm. Using the combined pipeline of MCFS and Rosetta, it was possible to predict AD among patients with MCI with an area under the receiver operating characteristics curve of 0.92. Risk estimates were produced for the individual patients and showed good correlation with actual diagnosis in cross validation, and on an external dataset from a new study. Analysis of the importance of attributes showed that the biochemical CSF markers contributed the most to the predictions, and that added value was gained by combining several biochemical markers. Despite a correlation with the biochemical markers, the genetic marker APOE epsilon 4 did not contribute to the predictive power of the model.

Publiceringsår

2012

Språk

Engelska

Sidor

821-831

Publikation/Tidskrift/Serie

Journal of Neural Transmission

Volym

119

Issue

7

Dokumenttyp

Artikel i tidskrift

Förlag

Springer

Ämne

  • Neurology

Nyckelord

  • Alzheimer's disease
  • Decision support
  • Monte Carlo feature selection
  • Rosetta
  • Rough sets
  • Biomarkers
  • Cerebrospinal fluid

Status

Published

Forskningsgrupp

  • Clinical Memory Research

ISBN/ISSN/Övrigt

  • ISSN: 0300-9564